Trials / Terminated
TerminatedNCT00850421
Pilot Study of BOTOX for Migraine Headaches
A Single-Center Pharmacoeconomic Pilot Study of BOTOX® (Botulinum Toxin Type A) for the Prophylactic Treatment of Migraine Headaches
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- HealthPartners Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purposes of this study are to assess whether subjects treated with BOTOX will: 1. have a decrease in the frequency and intensity of migraine headaches 2. experience improvements in quality of life 3. experience a reduction in the frequency of health care services obtained.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum Toxin Type A | 100 Units - Dilution: 25U/ml (4:1 BOTOX/preservative free saline) |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-02-25
- Last updated
- 2018-09-26
- Results posted
- 2013-09-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00850421. Inclusion in this directory is not an endorsement.